Navigation Links
IDEXX Laboratories Names William Brown Corporate Vice President
Date:12/8/2008

WESTBROOK, Maine, Dec. 8 /PRNewswire-FirstCall/ -- IDEXX Laboratories, Inc. (Nasdaq: IDXX), today announced the appointment of William E. Brown, PhD as Corporate Vice President, Instrument Research and Development (R&D) and Manufacturing. In this capacity, Dr. Brown will oversee instrument development, manufacturing, and the worldwide supply network.

"Bill's extensive R&D and manufacturing management experience is distinctively relevant to IDEXX's strategy of technological innovation in diagnostics and information technology," said Jonathan Ayers, Chairman and CEO. "He brings a unique combination of expertise in several functions, including product development, manufacturing, and quality assurance for both life science and instrument systems."

"I am very excited to be joining IDEXX," said Dr. Brown. "As an innovation leader, IDEXX provides unique products and services that benefit its customers. I am looking forward to being part of the future of this outstanding company."

Dr. Brown comes to IDEXX having retired in 2007 from his position as Corporate Officer, Vice President of R&D, Assays and Systems for the Diagnostic Division of Abbott Laboratories, Inc. During his twenty-five years with Abbott, Dr. Brown held various senior leadership positions, including oversight of the R&D portfolio development, new product launches, and basic research for immunoassay and clinical chemistry and instrument systems.

Dr. Brown earned his BS in chemistry education from Indiana University of Pennsylvania and his PhD in medicinal chemistry from the University of Pittsburgh, School of Pharmacy.

About IDEXX Laboratories

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,500 people and offers products to customers in over 100 countries.

Contact: Merilee Raines, Chief Financial Officer (207) 556-8155


'/>"/>
SOURCE IDEXX Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
2. IDEXX Laboratories to Release 2008 First Quarter Financial Results
3. IDEXX Laboratories Announces Increase in Share Repurchase Program
4. IDEXX Laboratories Announces Fourth Quarter Results
5. IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
6. IDEXX Laboratories to Present at JPMorgan Healthcare Conference
7. Stiefel Laboratories Announces the Expansion of Its REVALESKIN(R) Skin Care Line With Three New Products
8. Forest Laboratories Responds To Unsolicited Mini-Tender Offer
9. Caraco Pharmaceutical Laboratories, Ltd. Responds to FDA Warning Letter
10. Caraco Pharmaceutical Laboratories, Ltd. Update on FDA Warning Letter
11. Carma Laboratories Launches New Carmex(R) Web Site; Unveils Top 10 Reasons for a Virtual Visit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... The ... the Rhode Island Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to ... autism spectrum disorder (ASD) to see films in an environment that accommodates their ...
(Date:2/23/2017)... Ramon, CA (PRWEB) , ... February 23, 2017 , ... ... MD, FACP, FACMPE, FACPE, will keynote their upcoming conference – Empowerment, Value and Collaboration ... as the chairman and CEO of the Virginia Mason Health System in Seattle since ...
(Date:2/23/2017)... York (PRWEB) , ... February 23, 2017 , ... Curemark, ... the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now ... clinical sites already enrolling children across the United States. , “There are currently ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Thomas ... perseverance and disciplined exercise regime, the author was able to successfully recover. In “ ... all relevant information for various sources on the principals of massage, anatomy , ...
(Date:2/22/2017)... ... February 22, 2017 , ... When it came time ... center in Georgia, PENETRON Specialty Products (PSP) provided the solution. January’s grand opening ... invested $51 million to purchase and renovate the 185,000 square-foot office complex, which ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and ...
(Date:2/23/2017)... 2017 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... release fourth quarter and yearly financial results after ... management will host an investment-community conference call at ... on March 2 nd 2017 to discuss ...
(Date:2/23/2017)... , February 23, 2017 ... from increasing caseload for varicose veins in their body. ... globe are prompting the adoption of endovenous laser therapy ... global endovenous laser therapy market, published by ... of lifestyle choices and consequences of obesity have collectively ...
Breaking Medicine Technology: